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I am a product of the city and the suburbs. My only contact with farms as a
boy was to lean my head out of the car window and try to communicate with
cows when we drove through the country. My first contact with agriculture as
a reporter came in 1988, when I went to an Agricultural Research Conference
in Beltsville, Maryland. There I heard ominous phrases I hadn’t heard before —
talk of “genetic erosion” and “seed morgues.” The conference was on the
subject of germplasm preservation. One speaker after another stood at the
podium proclaiming a crisis in the national germplasm preservation system.
As an environmental writer, I was interested in biological diversity, but
at that conference I learned about an example of biological diversity that I
had not heard of before. If I asked what place on Earth contained the most
biological diversity, you might answer that it must be somewhere in the tropical
rainforest. But I’m not sure that’s right. I know a place where I can identify
500,000 genetically distinct organisms in the space of a few thousand square
feet — an example of diversity that transcends even the incredible natural
diversity of tropical rainforests. The place I have in mind is the National Seed
Storage Laboratory in Fort Collins, CO. It’s a fantastic repository of genetic
diversity, containing thousands of varieties of corn and beans and wheat — and
virtually every other crop you might name.
I mention it partly because it hasn’t been mentioned during the conference,
and, from the perspective of scientific research, I think it is important. The
National Seed Storage Laboratory is one of the foundations on which bio-
technology is built. We often think of biotechnology as almost a magical thing,
capable of creating any kind of crop we can imagine. But biotechnology is
actually a very limited thing: it can move genes around and manipulate them,
take them from one species and put them into any other species. But, at
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present, it is utterly unable to create entirely new genes that do entirely new
things. From a scientific point of view, it is important to remember that without
a treasure chest of genetic diversity, biotechnology isn’t much good. There are
many genes in that treasure trove that could produce crops that might solve
some of the problems we’ve been discussing during the past few days. But there
are two problems: One is that the seed storage laboratories are not getting
enough money to preserve their collections. Seeds are living things, and they
don’t live forever. From time to time, they have to be taken out and planted,
and then the fresh seeds can be harvested and put back into storage. That is not
being done, and some of the sample envelopes in the seed storage laboratory
now contain nothing but lifeless dust.
A second problem is that biotechnology companies are motivated by short-
term financial considerations. They cannot choose genes to produce crops
that might help solve some of the social and financial problems we’ve been
discussing at this conference. If we want to use biotechnology to help feed the
world’s starving poor or serve other social aims that may not be profitable, we
have two options: We can persuade government to do it, or we can mobilize
public opinion to persuade biotechnology companies to donate technology to
those who will never be able to afford to buy it.
Another thing I would like to mention is a word that comes up all the time
in discussions at Business Week about economic trends. It’s a bit of a surprise to
me that it didn’t figure more into discussions here. The word is: Internet. The
Internet is transforming American business of all kinds, and it’s happening
extremely rapidly. To give you a New York example, the stock broker Merrill
Lynch has long said that it wasn’t interested in online trading on the Internet.
Merrill Lynch felt that it offered superior products and services, that its
knowledgeable brokers and researchers offered information that stock traders
would be happy to pay a premium for. A couple of weeks ago, Merrill Lynch
reversed course and said it would begin offering trading online. The economics
of the Internet were simply overwhelming. Trading on the Internet was so
much easier and cheaper than trading through a broker that Merrill Lynch was
losing customers. It had no choice but to join the trend.
So my question to you is: What opportunities does the Internet offer to
agriculture? How does it intersect with biotechnology? What, if anything, can
it do to help make this technology available to those who cannot now afford it?
One of the buzz words connected with the Internet is this mouthful: disinter-
mediation. It is a complex bit of jargon for a simple idea: The Internet is, in
many circumstances, removing the middle man in business transactions. People
who want to buy stock don’t need a broker. They can deal directly with the
market. People can look at schedules and fares in airline computers without
needing to consult a travel agent. Increasingly, it is possible to deal with whole-
salers directly, avoiding retail markup. At this conference, many speakers have
talked about the long chain between farmers and end-users. What can the
Internet do to shorten those long lines? I’m not talking about using the
Internet as a research tool, or a communications tool. Those are important,
but that is already happening. I’m talking about using the Internet as a market-
ing tool. What are the opportunities for E-commerce in agriculture? There
might be a thousand reasons why I cannot sit in New York and order beef
directly from a Nebraska farmer on the Internet. But maybe not. It’s a question
worth exploring.
And while we are on the subject of the long lines between farmers and end
users, I think it is important to remind you how little we know from our perch
in New York. This is the view from Times Square. Given the extremely rapid
adoption of genetically modified crops in Nebraska and elsewhere in the
Midwest, I assume I am now eating meat in New York that has been fed with
genetically modified feed. Is that a reason for concern? It’s hard to say. During
the past few days, we have heard a lot of questions raised about the safety of
genetically engineered crops. And we have heard just as many assurances that
there is nothing to worry about. It will be a difficult issue to resolve. But one
thing is very clear: many people are concerned about the potential health
dangers of genetically modified crops, and that is an important thing to think
about — whether they are right or wrong to be concerned. The point is that, in
New York, we don’t know, when we shop at the supermarket, whether we are
buying food that ultimately comes from genetically engineered crops. The issue
has been widely discussed in Nebraska by farmers, by researchers, and by those
in the biotechnology industry. But it hasn’t yet been widely discussed in New
York, or in Washington, or in the press. Those discussions need to take place if
people are to become informed about genetically engineered crops and make
intelligent decisions about them.
As people discover that this revolution in agriculture took place without
any national debate, they might decide they have been hoodwinked — and
that could lead to a backlash in which many would decide to reject these
foods out of hand. Many people might be perfectly happy to eat genetically
modified foods, but nobody likes to be fooled. The monarch butterfly has been
mentioned repeatedly during the conference. In the coming months, we might
all forget about the monarch butterfly study. We really don’t know whether
monarchs are exposed to Bt pollen, and this concern might completely
disappear.
Or it might not. Rachel Carson’s cause got huge visibility in part because of
her eloquent advocacy but also because the animal that was in danger was the
bald eagle — the symbol of the country. Trying to predict the fate of genetically
engineered foods is, at this point, a little like trying to predict what the stock
market will do in the coming months. It could soar. The Dow Jones index could
hit 12,000, or 15,000. But you would be prudent not to bet on it. Prices could
just as easily turn sharply down. I don’t know what the American public will
think about the monarch butterfly research a year from now, but it would be
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prudent to prepare for a public backlash. The monarch butterfly could turn out
to be the bald eagle of biotechnology. I happen to think biotechnology is an
important and useful tool. I don’t necessarily see a conflict between biotechnol-
ogy and alternative agriculture, or organic farming. I like to think of alternative
agriculture and organic farming as the “soft paths” in agriculture. Biotechnol-
ogy is the hard path. Both can help us get to a healthier, more profitable, more
environmentally sustainable kind of agriculture. Both can be used for the good
of consumers and for the good of farmers. Biotechnology can be used to
produce improved crop varieties for organic farmers, allowing them to produce
tastier foods and a wider variety of foods without using chemicals — and the
opportunity to use fewer pesticides and other chemicals could help win
consumer acceptance. Whether that happens will depend upon how this new
technology is used. Using it to sell more herbicide offers nothing to consumers,
and it isn’t going to earn their acceptance of crop biotechnology.
